Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical Implications
Authors:
- Patrick J. BastianPBPatrick J. Bastian
- Ballentine H. CarterBCBallentine H. Carter
- Anders BjartellABAnders Bjartell
- Michael SeitzMSMichael Seitz
- Peter StanislausPSPeter Stanislaus
- Francesco MontorsiFMFrancesco Montorsi
- Christian G. StiefCSChristian G. Stief
- Fritz SchröderFSFritz Schröder
- 1 June 2009
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 55 (6) , 1321-1332
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Early Detection of Prostate Cancer in 2007European Urology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on SurveillanceJournal of Urology, 2007
- Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005Urology, 2007
- Watching, waiting and uncertainty in prostate cancerJournal of Clinical Nursing, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of CurabilityJNCI: Journal of the National Cancer Institute, 2006
- Active surveillance with selective delayed intervention for favorable risk prostate cancerUrologic Oncology: Seminars and Original Investigations, 2006
- Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancerNature Reviews Endocrinology, 2005
- Quality improvement report Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study Commentary: presenting unbiased information to patients can be difficultBMJ, 2002